Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Oct 04, 2021 12:24am
228 Views
Post# 33959607

RE:We should trust someone who took the company from 1.50 to

RE:We should trust someone who took the company from 1.50 to.145  this year , he has no sense of FDA time, Phase 2 not finished could take a year, Phase 3 could take years, Phase 4 could take years ,THEN THEY CAN APPLY FOR DIN not before .He is buying himself a job...company will never go above .40 until the warrants expire in  July 12,2022 .
Nothing has changed in months and here we go again saying the stock is worth 3.00 based on hype, it is at .235 today because he sold 65,000,000 shares at .22 cents this spring  and gave warrants at .28 for years  you don't think that effects the future and present price.Put the rockets away, total garbage .Syqe has approval and their own unit and product  , they didn,t have to borrow one from another company to do their study like Tetra did.Panga is doing the research, they borrowed the mighty medic from Canopy Growth, they don't even have their own lab. Nothing new maybe more fake news and hype, just wait for the results. 
<< Previous
Bullboard Posts
Next >>